搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
NKyTribune
22 小时
St. E. Healthy Headlines: Anxiety impacts the mind and the body — when and how to get help
St. Elizabeth Healthcare Is anxiety a mood disorder or is it a physical reaction to emotional stress? The answer is that it ...
HealthDay on MSN
3 天
Anxiety: Symptoms, Causes, Treatments, Medications & More
Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.
Future Market Insights
4 天
Global Cannabis Use Disorder Treatment Market Projected to Reach USD 2.66 Billion by 2033 ...
Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...
YourTango
11 天
The Relaxing Song That Will Cut Your Anxiety In Half, According To Research
The musicians teamed up with sound therapists to create music that could lower the heart rate, blood pressure, and actual ...
10 天
Mindfulness may be as effective as antidepressant for anxiety symptoms
Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...
6 天
Seaport Therapeutics raises another $225 million to embrace ‘golden age of neuroscience’
The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...
3 天
on MSN
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For ...
The United States Patent and Trademark Office (USPTO) has granted U.S. patent 12,122,741, which claims the composition of ...
3 天
on MSN
Is there a 2024 Duloxetine recall? FDA flags 7,100+ bottles of generic Cymbalta antidepressants
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
3 天
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...
12 天
Cybin: Top Value Psychedelic Stock
Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...
Neurology Advisor
4 天
Prescription Digital Therapeutic for Insomnia Improves Sleep and Mental Health
A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.
3 天
AbbVie, Gedeon Richter collaborate for discovery, development of novel targets
AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈